EP Patent

EP0295917A3 — Non-invasive hypodermic injection device

Assigned to Bioject Inc · Expires 1989-03-22 · 37y expired

What this patent protects

A non-invasive hypodermic injection device (10) includes a two-stage gas delivery system and a medication containing ampule (32) having a truncated hypodermic needle (44) at one end thereof. An ampule shroud (52) encloses the ampule and maintains separation between the truncat…

USPTO Abstract

A non-invasive hypodermic injection device (10) includes a two-stage gas delivery system and a medication containing ampule (32) having a truncated hypodermic needle (44) at one end thereof. An ampule shroud (52) encloses the ampule and maintains separation between the truncated hypodermic needle (44) on the ampule and the skin of a patient being injected.

Drugs covered by this patent

Patent Metadata

Patent number
EP0295917A3
Jurisdiction
EP
Classification
—
Expires
1989-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Bioject Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.